Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

J Hepatol. 2017 Jan;66(1):236-237. doi: 10.1016/j.jhep.2016.08.016. Epub 2016 Aug 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • Carcinoma, Hepatocellular*
  • Hepatitis C
  • Humans
  • Liver Neoplasms
  • Neoplasm Recurrence, Local*

Substances

  • Antiviral Agents